Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 USD | +0.87% | +9.07% | -81.37% |
14/05 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
10/05 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.37% | 160M | |
+9.99% | 114B | |
+12.01% | 107B | |
-3.07% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.90% | 17.51B | |
-39.36% | 17.17B | |
+5.82% | 14.14B | |
+33.05% | 12.2B |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- Barclays Downgrades RAPT Therapeutics to Equalweight, Price Target at $4